Ansprechpartner und Kontakt

Priv.-Doz. Dr. Dr. Jan Dirk Raguse

Facharzt für Mund-, Kiefer- und Gesichtschirurgie
Plastische und Ästhetische Operationen

Berufliche Ausbildung

Qualifikation und Weiterbildung

Akademische Ausbildung

Mitgliedschaften und Funktionen

• Deutsch Österreichisch Schweizerischer Arbeitskreis für Tumoren im Kiefer- und Gesichtsbereich e.V. (DÖSAK e.V.) – seit 2013 Schatzmeister und Mitglied des Vorstands
• Deutsche Gesellschaft für Mund-, Kiefer- und Gesichtschirurgie (DGMKG)
• International Academy of Oral Oncology (IAOO)
• Arbeitsgemeinschaft für Kieferchirurgie (AGKI)
• European Board of Oral-Maxillofacial Surgery
• European Association for Cranio-Maxillofacial Surgery
• Deutsche Krebsgesellschaft, Arbeitsgruppe Kopf-Hals-Tumore
• Deutsches Konsortium für Translationale Krebsforschung (DKTK)

Publikationsverzeichnis

1. Gath HJ, Hell B, Zarrinbal R, Bier J, Raguse JD. Regeneration of intraoral defects after tumour resection with a bioengineered human dermal replacement (Dermagraft), Plast Reconstr Surg. 3/2002, 889-93 (109)  IF 1,629
2. Gath HJ, Raguse JD. Use of Dermagraft in plastic and reconstructive surgery, The Canadian Journal of Plastic Surgery, 1/2002, 95-9 (10A) IF 0,21
3. Raguse JD, Gath HJ, Bier J, Riess H, Oettle H. Cilengitide (EMD 1219744) arrests the growth of a heavily pretreated highly vascularized head neck tumour, Oral Oncology. 2/2004, 228-30 (40) IF 1,876
4. Raguse JD, Gath HJ, Oettle H, Bier J Docetaxel (Taxotere) in Recurrent High Grade Mucoepidermoid Carcinoma of the Major Salivary Glands, Oral Oncology Extra. 1/2004, 5-7 (40) IF 1,876
5. Raguse JD, Schwerdtner O, Klein M, Bier J. Ästhetische Rehabilitation beim Rhinophym, MKG-Chirurgie. 1/2004, 24-7 (8)
6. Raguse JD, Gath HJ. The buccal fad pad lined with a metabolic active dermal replacement (Dermagraft) for treatment of defects of the buccal plane,  Br J Plast Surg. 8/2004, 764-8 (57) IF 1,08
7. Raguse JD, Gath HJ. A metabolically active dermal replacement (Dermagraft) for Vestibuloplasty, J Oral Rehab, 5/2005, 337-40 (32)  IF 1,934
8. Raguse JD, Gath HJ, Bier J, Riess H, Oettle H. Gemcitabine in the treatment of advanced head and neck cancer, Clin Oncol, 9/2005 Sep, 425-9 (17) IF 2,826
9. Raguse JD, Gath HJ, Oettle H, Bier J. Oxaliplatin, Folinic acid and 5-Fluorouracil (OFF) in patients with recurrent advanced head and neck cancer: A phase II Feasibility Study. Oral Oncology. 7/2006, 614-8 (42) IF 1,876
10. Raguse JD, Bezeluk A, Bier J, Klein M. The central island tongue flap for the reconstruction of the anterior floor of the mouth, MKG-Chirurgie, 1/2007, 53-57 (11)
11. Fabricius EM, Wildner GP, Kruse-Boitschenko U, Hoffmeister B, Goodman SL, Raguse JD. Immunohistochemical analysis of integrins αvβ3, αvβ5 and α5β1, and their ligands, fibrinogen, fibronectin, osteopontin and vitronectin, in frozen sections of human oral head and neck squamous cell carcinomas, Exp Ther Med, 1/2011, 9-19 (2) IF 0,941
12. Fabricius EM, Kruse-Boitschenko U, Schneeweiss U, Wildner GP, Hoffmeister B, Raguse JD. Model examination of chemoprevention with retinoids in squamous cell carcinomas of the head and neck region and suitable biomarkers for chemoprevention, Int J Oncol, 11/2011, 1083-97 (39) IF 2,733
13. Raguse JD, Camerer C, Bergmann F, Schewe C, Schürmann D.Occupational syphilis following scalpel injury. Ann Intern Med, 3/2012, 475-6 (156) IF 4,41
14. Tinhofer I, Jöhrens K, Keilholz U, Kaufmann A, Lehmann A, Weichert W, Stenzinger A, Stromberger C, Klinghammer K, Becker ET, Dommerich S, Stölzel K, Hofmann VM, Hildebrandt B, Moser L, Ervens J, Böttcher A, Albers A, Stabenow R, Reinecke A, Budach V, Hoffmeister B, Raguse JD. Contribution of human papilloma virus to the incidence of squamous cell carcinoma of the head and neck in a European population with high smoking prevalence. Eur J Cancer. 3/2015, 514-21 (51) IF 5,626
15. Adolphs N, Ernst N, Hoffmeister B, Raguse JD. Transpalatal distraction for the management of maxillary constriction in pediatric patients. Ann Maxillofac Surg. 1/2015, 44-8 (5)
16. Toso SM, Menzel K, Motzkus Y, Adolphs N, Hoffmeister B, Raguse JD. Patient-Specific Implant in Prosthetic Craniofacial Reconstruction: First Report of a Novel Technique With Far-Reaching Perspective. J Craniofac Surg. 10/2015, 2133-5 (26) IF 0,7
17. Doll C, Arsenic R, Lage H, Jöhrens K, Hartwig S, Nelson K, Raguse JD. Expression of Estrogen Receptors in OSCC in Relation to Histopathological Grade. Anticancer Res. 11/2015, 5867-72 (35) IF 1,862
18. Raguse JD, Hossamo J, Tinhofer I, Hoffmeister B, Budach V, Jamil B, Jöhrens K, Thieme N, Doll C, Nahles S, Hartwig ST, Stromberger C. Patient and treatment-related risk factors for osteoradionecrosis of the jaw in patients with head and neck cancer. Oral Surg Oral Med Oral Pathol Oral Radiol. 03/2016, 215-221(121)  IF 1,262
19. Raguse JD, Czabanka M, Voss JO, Hartwig S, Vajkoczy P, Voss P, Doll C. The lower trapezius island myocutaneous flap in tunnelled technique to cover complicated tissue defects located between the craniocervical and cervicothoracic junction following spinal surgery. J Craniomaxillofac Surg. 08/2016, 969-72 (44) IF 1,592
20. Hartwig S, Doll C, Voss JO, Hertel M, Preissner S, Raguse JD. Treatment of Wound Healing Disorders of Radial Forearm Free Flap Donor Sites Using Cold Atmospheric Plasma: A Proof of Concept. J Oral Maxillofac Surg. 02/2017, 429-35 (75) IF 1,631
21. Hartwig S, Boettner A, Doll C, Voss JO, Hertel M, Preissner S, Raguse JD. Drill-related root injury caused by intraoperative intermaxillary fixation. An analysis of 1067 screw-applications. Dent Traumatol. 02/2017, 45-50 (33) IF 1,327
22. Hartwig S, Preissner S, Voss JO, Hertel M, Doll C, Waluga R, Raguse JD. The feasibility of cold atmospheric plasma in the treatment of complicated wounds in cranio-maxillo-facial surgery. J Craniomaxillofac Surg. 10/2017, 1724-1730 (45) IF 1,592
23. Raguse JD, Hartwig S, Pfitzner D, Preissner R, Paris S, Preissner S. Detection of signature volatile organic compounds in the breath of oral head and neck cancer patients: a pilot study. Otolaryngology–Head and Neck Surgery, 12/2017, 981-987 (157) IF 2,021
24. Raguse JD, Anagnostopoulos I, Doll C, Heiland M, Jöhrens K. Possible Estrogen Dependency in the Pathogenesis of Branchial Cleft Cysts. Biomed Res Int. 2017; 2017:1807056. doi: 10.1155/2017/1807056. Epub 2017 Dec 19 IF 2,476
25. Doll C, Dauter K, Jöhrens K, Hartwig S, Voss JO, Klein M, Heiland M, Raguse JD. Clinical characteristics and immunohistochemical analysis of p53, Ki-67 and cyclin D1 in 80 odontogenic keratocysts. J Stomatol Oral Maxillofac Surg. 2018 Mar 9. pii: S2468-7855(18)30069-7. [Epub ahead of print] IF 0,274
26. Voss JO, Thieme N, Doll C, Hartwig S, MD, Adolphs N, Heiland M, Raguse JD. Penetrating Foreign Bodies in Head and Neck Trauma: A Surgical Challenge. Craniomaxillofac Trauma Reconstruction. 2018 Sep;11(3):172-182 IF -
27. Doll C, MD, Thieme N, Schönmuth S, Voss JO, Nahles S, Beck-Broichsitter B, Heiland M, Raguse JD. Enhanced Radiographic Visualization of Resorbable Foils for Orbital Floor Reconstruction: A Proof of Principle. J Craniomaxillofac Surg. 2018 Sep; 46(9):1533-1538 IF 1,592
28. Voss JO, Buehling S, Thieme N, Doll C, Hauptmann K, Heiland M, Adolphs N, Raguse JD. Sublingual cysts of different entities in an infant - A case report and literature review. Int J Pediatr Otorhinolaryngol. 2018 Oct; 113:260-265 IF 1,125
29. Doll C, Carl F, Neumann K, Voss JO, Hartwig S, Waluga R, Heiland M, Raguse JD. Odontogenic Abscess-Related Emergency Hospital Admissions: A Retrospective Data Analysis of 120 Children and Young People Requiring Surgical Drainage. Biomed Res Int. 2018 Aug 26; 2018:3504727 IF 2,583
30. Neckel N, Lissat A, von Stackelberg A, Thieme N, Doueiri MS, Spors B, Beck-Broichsitter B, Heiland M, Raguse JD. Primary oral manifestation of Langerhans cell histiocytosis refractory to conventional therapy but susceptible to BRAF-specific treatment: a case report and review of the literature. Ther Adv Med Oncol. 2019 Oct 19;11
31. Hartwig S, Nissen MC, Voss JO, Doll C, Adolphs N, Heiland M, Raguse JD. Clinical outcome after orbital floor fracture reduction with special regard to patient's satisfaction. Chin J Traumatol. 2019 Jun 22(3):155-160 
32. Toso S, Nahles S, Herzog M, Motzkus Y, Heiland M, Raguse JD. Frontal sinus augmentation: Preliminary results of a new approach in prosthetic orbital reconstruction. J Craniomaxillofac Surg. 2019 Jun;47(6):984-990
33. Carl F, Doll C, Voss JO, Neumann K, Koerdt S, Adolphs N, Nahles S, Heiland M, Raguse JD. Following in the footsteps of Hippocrates-interrelation between the incidence of odontogenic abscess and meteorological parameters. Clin Oral Investig. 2019 Oct;23(10):3865-3870 

Orginalarbeiten (Co-Autor)

1. Oettle H, Riess H, Raguse JD, Bier J, Gath HJ. Recombinant human erythropoetin in the treatment of head and neck tumour anaemia. Int J Oral Max Surg. 4/2001, 148-55 (30)  IF 1,043
2. Bufe B, Hofmann T, Krautwurst D, Raguse JD, Meyerhof W. The human TAS2R16 receptor mediates bitter taste in response to ß-glycopyranoides. Nat Gen. 11/2002, 397-401 (32)  IF 26,494
3. Shirokova E, Schmiedeberg K, Bedner P, Niessen H, Willecke K, Raguse JD,  Meyerhof W, Krautwurst D. Identification of specific ligands for orphan olfactory receptors. G protein-dependent agonism and antagonism of odorants. J Biol Chem. 4/2005, 11807-15 (280)  IF 6,482
4. Behrens M, Foerster S, Staehler F, Raguse JD, Meyerhof W. Gustatory expression pattern of the human TAS2R bitter receptor gene family reveals a heterogenous population of bitter responsive taste receptor cells. J Neurosci. 11/2007, 12630-40 (46)  IF 13,330
5. Shirokova E, Raguse JD, Meyerhof W, Krautwurst D. The human vomeronasal type-1 receptor family – detection of volatiles and cAMP signalling in HeLa/Olf cells. The FASEB Journal. 5/2008, 1416-25 (22) IF 11,880
6. Stähler F, Riedel K., Demgensky S, Neumann K, Dunkel A, Täubert A, Raab B, Behrens M, Raguse JD, Hofmann T, Meyerhof W.  A role of the epithelial sodium channel in human salt taste transduction? Chemosensory Perception. 2/2008, 78–90 (1) IF 1,365
7. Fabricius EM, Kruse-Boitschenko U, Khoury R, Wildner GP, Raguse JD, Klein M. Immunohistochemical determination of the appropriate anti-hTERT antibodies for in situ detection of telomerase activity in frozen sections of head and neck squamous cell carcinomas and tumor margin tissues. Int J Oncol. 5/2009,1257-79 (34) IF 2,447
8. Adolphs N, Sproll C, Raguse JD, Nelson K, Heberer S, Scheifele C, Klein M. Stable vertical distraction osteogenesis of highly atrophic mandibles after ablative tumour surgery of the oral cavity--a salvage pathway for mandibular reconstruction prior to oral rehabilitation with dental implants J Cranio Maxill Surg. 9/2009, 320-6 (37) IF 1,252
9. Fabricius EM, Kruse-Boitschenko U, Khoury R, Wildner GP, Raguse JD, Klein M, Hoffmeister B. Localization of telomerase hTERT protein in frozen sections of basal cell carcinomas (BCC) and tumor margin tissues. Int J Oncol. 12/2009, 1377-94 (35) IF 2,447
10. Heberer S, Deniz-Kilic S, Hossamo J, Raguse JD, Nelson K. Rehabilitation of irradiated patients with modified and conventional SLA implants: Preliminary results of a split mouth study. Clin Oral Implants Res. 5/2011, 546-51 (22) IF 2,214
11. Galindo MM, Voigt N, Stein J, van Lengerich J, Raguse JD, Hofmann T, Meyerhof W, Behrens M. G Protein-Coupled Receptors in Human Fat Taste Perception. Chemical Senses. 2/2012, 123-39 (37) IF 3,222
12. Behrens M, Born S, Redel U, Voigt N, Schuh V, Raguse JD, Meyerhof W. Immunohistochemical detection of TAS2R38 protein in human taste cells. PLoS ONE. 7/2012, e40304 (7) IF 3,730
13. Voigt N, Stein J, Galindo MM, Dunkel A, Raguse JD, Meyerhof W, Hofmann T, Behrens M. The role of lipolysis in human orosensory fat perception. J Lipid Res. 5/2014, 870-82 (55) IF 4,386
14. Tinhofer I, Konschak R, Stromberger C, Raguse JD, Dreyer JH, Jöhrens K, Keilholz U, Budach V. Detection of circulating tumor cells for prediction of recurrence after adjuvant chemoradiation in locally advanced squamous cell carcinoma of the head and neck. Ann Oncol. 10/2014, 2042-7 (25) IF 6,578
15. Stromberger C, Jann D, Becker ET, Raguse JD, Tinhofer I, Marnitz S, Budach V. Adjuvant simultaneous integrated boost IMRT for patients with intermediate- and high-risk head and neck cancer: Outcome, toxicities and patterns of failure. Oral Oncology. 9/2014, [Epub ahead of print] IF 3,029
16. Nack C, Raguse JD, Stricker A, Nelson K, Nahles S. Rehabilitation of irradiated patients with chemically modified and conventional SLA implants: five-year follow-up. J Oral Rehab. 9/2014, [Epub ahead of print] IF 1,934
17. Klinghammer K, Raguse JD, Plath T, Albers AE, Joehrens K, Zakarneh A, Brzezicha B, Wulf-Goldenberg A, Keilholz U, Hoffmann J, Fichtner I. A comprehensively characterized large panel of head and neck cancer patient-derived xenografts identifies the mTOR inhibitor everolimus as potential new treatment option. Int J Cancer. 11/2014, [Epub ahead of print] IF 5,007
18. Doll C, Nack C, Raguse JD, Stricker A, Duttenhoefer F, Nelson K, Nahles S. Survival analysis of dental implants and implant-retained prostheses in oral cancer patients up to 20 years. Clin Oral Invest. 11/2014, 1347-52 (19)  IF 2,285
19. Opitz D, Camerer C, Camerer DM, Raguse JD, Menneking H, Hoffmeister B, Adolphs N. Incidence and management of severe odontogenic infections-a retrospective analysis from 2004 to 2011. J Craniomaxillofac Surg. 3/2015, 285-9 (43) IF 1,592
20. Duttenhoefer F, Nack C, Doll C, Raguse JD, Hell B, Stricker A, Nelson K, Nahles S. Long-term peri-implant bone level changes of non-vascularized fibula bone grafted edentulous patients. J Craniomaxillofac Surg. 6/2015, 611-5 (43) IF 1,592
21. Fretwurst T, Wanner L, Nahles S, Raguse JD, Stricker A, Metzger MC, Nelson K. A prospective study of factors influencing morbidity after iliac crest harvesting for oral onlay grafting. J Craniomaxillofac Surg. 6/2015, 705-9 (43) IF 1,592
22. Fretwurst T, Nack C, Al-Ghrairi M, Raguse JD, Stricker A, Schmelzeisen R, Nelson K, Nahles S. Long-term retrospective evaluation of the peri-implant bone level in onlay grafted patients with iliac bone from the anterior superior iliac crest. J Craniomaxillofac Surg. 7/2015, 956-60 (43) IF 1,592
23. Stromberger C, Wlodarczyk W, Marnitz S, Jamil B, Budach V, Raguse JD, Boettcher A, Badakhshi H. Simultaneous Integrated Boost (SIB): RapidArc and Tomotherapy Plan Comparison for Unilateral and Bilateral Neck Irradiation. Anticancer Res. 5/2015, 2991-7 (35)  IF 1,862
24. Voss JO, Raguse JD, Hoffmeister B, Adolphs N. Magnetic resonance imaging induced acute midfacial pain - incidental finding of a dislocated dental bur. Eur J Oral Implantol. 6/2015,183-7 (8) IF 2,328
25. Toso SM, Menzel K, Motzkus Y, Klein M, Menneking H, Raguse JD, Nahles S, Hoffmeister B, Adolphs N.Anaplastology in times of facial transplantation: Still a reasonable treatment option? J Craniomaxillofac Surg. 9/2015, 1049-53 (43)  IF 1,592
26. Stromberger C, Ghadjar P, Marnitz S, Thieme AH, Jahn U, Raguse JD, Karaj-Rossbacher E, Böttcher A, Jamil B, Budach V. Comparative treatment planning study on sequential vs. simultaneous integrated boost in head and neck cancer patients: Differences in dose distributions and potential implications for clinical practice. Strahlenther Onkol. 10/2015 [Epub ahead of print]  IF 2,898
27. Voss JO, Varjas V, Raguse JD, Thieme N, Richards RG, Kamer L. Computed tomography-based virtual fracture reduction techniques in bimandibular fractures. J Craniomaxillofac Surg. 02/2016, 177-85 (44)  IF 1,592
28. Pierdzioch P, Hartwig S, Herbst SR, Raguse JD, Dommisch H, Abu-Sirhan S, Wirtz HC, Hertel M, Paris S, Preissner S. Cold plasma: a novel approach to treat infected dentin-a combined ex vivo and in vitro study. Clin Oral Invest. 02/2016, 177-85 (44)  IF 2,207
29. Stromberger C, Cozzi L, Budach V, Fogliata A, Ghadjar P, Wlodarczyk W, Jamil B, Raguse JD, Böttcher A, Marnitz S. Unilateral and bilateral neck SIB for head and neck cancer patients: Intensity-modulated proton therapy, tomotherapy, and RapidArc. Strahlenther Onkol. 04/2016, 232-239 (192) IF 2,898
30. Voss JO, Dieke T, Doll C, Sachse C, Nelson K, Raguse JD, Nahles S. Retrospective long-term analysis of bone level changes after horizontal alveolar crest reconstruction with autologous bone grafts harvested from the posterior region of the mandible. J Periodontal Implant Sci. 04/2016, 72-83 (46) IF 1,108
31. Voss JO, Hartwig S, Doll C, Hoffmeister B, Raguse JD, Adolphs N. The "tight orbit": Incidence and management of the orbital compartment syndrome. J Craniomaxillofac Surg. 08/2016, 1008-14 (44) IF 1,592
32. Ernst N, Sachse C, Raguse JD, Stromberger C, Nelson K, Nahles S. Changes in Peri-Implant Bone Level and Effect of Potential Influential Factors on Dental Implants in Irradiated and Nonirradiated Patients Following Multimodal Therapy Due to Head and Neck Cancer: A Retrospective Study. J Oral Maxillofac Surg. 10/2016, 1965-73 (74) IF 1,631
33. Nelson K, Stricker A, Raguse JD, Nahles S. Rehabilitation of irradiated patients with chemically modified and conventional SLA implants: a clinical clarification. J Oral Rehabil. 11/2016, 871-872 (43) IF 1,934
34. Jöhrens K, Anagnostopoulos I, Dommerich S, Raguse JD, Szczepek AJ, Klauschen F, Stölzel K. Expression patterns of CD168 correlate with the stage and grade of squamous cell carcinoma of head and neck. Mol Clin Oncol. 4/2017, 597-602 (6) IF 1,5
35. Toso SM, Menzel K, Raguse JD, Nahles S. Survival Analysis of Orbital Implants and Potential Influencing Factors: A Retrospective Long-Term Study. Int J Oral Maxillofac Implants. 5/2017, 642-648 (32) IF 1,859
36. Klinghammer K, Otto R, Raguse JD, Albers AE, Tinhofer I, Fichtner I, Leser U, Keilholz U, Hoffmann J.  Basal subtype is predictive for response to cetuximab treatment in patient-derived xenografts of squamous cell head and neck cancer. Int J Cancer. 9/2017, 1215-1221 (141) IF 6,513
37. Voß JO, Thieme N, Märdian S, Doll C, Hartwig S, Heiland M, Raguse JD, Adolphs N. [Frequency and management of complex facial fractures-an oral and maxillofacial surgical assessment]. Unfallchirurg. 2019 Sep;122(9):711-718 

Orginalarbeiten (Fallbeschreibungen)

1. Raguse JD, Gath HJ, Oettle H, Bier J. Interferon-induced remission of a rapidly growing aggressive fibromatosis in the temporal fossa. Int J Oral Max Surg. 09/2004, 606-9 (33)
2. Raguse JD, Menneking H, Klein M, Bier J. Benign symmetric lipomatosis (Madelung's disease) complicated by involvement of the facial nerve. Eur J Plast Surg. 9/2004. 306-8 (27)
3. Raguse JD, Menneking H, Scholmann HJ, Bier J. Manifestation of Carcinoma cuniculatum in the mandible. Oral Oncol Extra. 4/2006, 173-175 (42)
4. Raguse JD, Pfitzmann R, Bier J, Klein M. Lower-extremity lymphedema following neck dissection - an uncommon complication after cervical ligation of the thoracic duct. Oral Oncol. 9/2007, 835-7 (43)
5. Kim DM, Camerer C,  Lojewski C, Buckendahl AC, Hoffmeister B, Raguse JD. Vom Zahnarztstuhl auf die Lungentransplantationsliste - Ein fulminanter Verlauf nach gewöhnlicher Weisheitszahnentfernung. Der MKG-Chirurg. 3/2011 223-28 (4)
6. Doll C, Hartwig S, Nack C, Nahles S, Nelson K, Raguse JD. Dramatic course of osteomyelitis in a patient treated with immediately placed dental implants suffering from uncontrolled diabetes: A case report. Eur J Oral Implantol. 10/2015, 405-10 (8)
7. Hartwig S, Doll C, Voss JO, Raguse JD. Severe tooth loss after root damage caused by predrilled intermaxillary fixation screw: a case report. Dent Traumatol. 10/2016, 425-7 (32)

Buchkapitel

1. Klein M, Raguse JD. Eingriffe im Kopf- und Halsbereich. In: Aulbert E, Nauck F, Radbruch R. (Hrsg.) Lehrbuch der Palliativmedizin,  2. Auflage. Schattauer, Stuttgart, 572-588,  2008
2. Meyerhof W, Reichling C, Brockhoff A, Förster S, Bufe B, Kuhn C, Raguse JD, Behrens M. Structure and function of human bitter taste receptors. In: Hofmann, T., Meyerhof, W., Schieberle, P. (eds.) Recent Highlights in Flavor Chemistry & Biology (Proceedings of the 8th Wartburg Symposium). Deutsche Forschungsanstalt für Lebensmittelchemie, Garching, 11-16, 2008
3. Werner JA, Keilholz U, Müller RP, Raguse JD. Kopf-Hals-Tumore. In: Schlag P, Bamberg M, Jäger D. (Hrsg.) Interdisziplinäre Entscheidungswege in der Onkologie. Deutscher Ärzte Verlag, Köln, 47-53, 2011
4. Klein M, Raguse JD. Eingriffe im Kopf- und Halsbereich. In: Aulbert E, Nauck F, Radbruch R. (Hrsg.) Lehrbuch der Palliativmedizin, 3. Auflage. Schattauer, Suttgart, 572-589, 2012
5. Galindo MM, Voigt N, Stein J, Raguse JD, Hofmann T, Meyerhof W, Behrens M. A role of fatty acids and their receptors in human fat taste perception? In: Hofmann, T., Meyerhof, W., Schieberle, P. (eds.) Advances and Challenges in Flavor Chemistry and Biology (Proceedings of the 9th Wartburg Symposium on Flavor Chemistry & Biology) Deutsche Forschungsanstalt für Lebensmittelchemie, Garching, 8-14, 2011
6. Fabricius EM, Hoffmeister Bodo, Raguse JD. Molecularbiology of Basal Cell Carcinoma. In: Madan V. (Hrsg.) Basal Cell Carcinoma. InTech, 19-55, 2012
7. Raguse JD, Hoffmeister, Schmelzeisen R, Nelson K, Hamm B, Thieme N. Status of computed tomography in therapy decision in patients with primary squamous cell carcinoma of the oral cavity – from a surgeon’s perspective. In: Greenberg AM (ed.) Craniomaxillofacial Reconstructive and Corrective Bone Surgery, 2nd ed. Springer, Heidelberg
8. Schmelzeisen R, Gellrich NC, Voss PJ, Raguse JD, Fretwurst T.Primary Management of Soft Tissue Trauma and Nerve Reconstruction. In: Brennan P, Schliephake H, Ghali GE, Cascarini L.  Maxillofacial Surgery, 3rd ed. Elsvier

Proceedings/Supplements

1. Raguse JD, Rein K, Bier J, Gath HJ. Cytostatic therapy with Gemcitabine (GEM) for patients with squamous cell carcinoma of the head-neck (scchn) after multiple previous treatments, J Canc Res Clin Oncol, 1999,  119 (125(S2))
2. Raguse JD, Rein K, Oettle H, Hell B, Bier J, Gath HJ. Treatment of tumour anaemia in patients with squamous cell carcinoma of the head and neck (SCCHN) with a recombinant human erythropoietin, J Craniofac Surg,  2000, 130 (28(S3))
3. Raguse JD, Rein K, Oettle H, Hell B, Bier J, Gath HJ. Immunonutrition: a new supportive treatment in head and neck cancer patients. J Craniofac Surg, 2000, 130 (28(S3))
4. Raguse JD, Gath JH, Bier J. Phase II trial of radiation therapy (RT) concurrent with gemcitabine (GEM) followed by chemotherapy with gem for unresectable SCCHN, Procedings Annual Meeting American Society Clinical Oncology, 2002, A963 (21)
5. Raguse JD, Bier J, Gath HJ. Regeneration of intraoral defects after tumour resection with a bioengineered human dermal replacement (Dermagraft). J Oral and Max Surg, 2002, 18 (30(S1))
6. Raguse JD, Oettle H, Bier J, Riess H, Gath HJ Phase II Trial of Radiation (RT) concurrent with Gemcitabine (Gem) followed by chemotherapy with Gem for unresectable scchn, J Oral and Max Surg, 2002, 55 (30(S1))
7. Raguse JD, Wust P, Gath HJ, Bier J, Riess H, Oettle H. Phase II trial of radiation concurrent with Gem for unresectable scchn. Onkologie, 2003, 36 (26(S5))
8. Raguse JD, Wust P, Gath HJ, Bier J, Riess H, Oettle H. Radiation (RT) Concurrent with Gemcitabine (Gem) for unresectable squamous cell Carcinoma in the head and neck (scchn), A phase II Trial, Oral Oncol, 2005, 126 (4(S1))
9. Raguse JD, Bier J, Oettle H. Oxaliplatin, Folinic Acid and 5-Fluorouracil (OFF) in Recurrent Advanced Head and Neck Cancer, A Phase II-Trial, Archives of Otolaryngology - Head and Neck Surgery, 2006, 869 (132(8))
10. Raguse JD. The central island tongue flap in reconstruction of the anterior floor of mouth. Oral Oncol, 2007, 156 (2(S1))
11. Fabricius EM, Wildner GP, Schneeweiss U, Raguse JD. Is the evidence of telomerase or hTERT (human telomerase reverse transcriptase) in the carcinoma-free margin tissues associated with the invasive progression of head and neck tumors? Onkologie, 2010, 124 (33(S 2))
12. Klinghammer K, Raguse JD, Siedmann M, Becker M, Keilholz U, Hoffmann J, Fichtner I. Identification of new treatment options for platinum-resistant head and neck cancer in a panel of broadly characterized patient-derived xenografts. [abstract]. In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research; 2013 Apr 6-10; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2013;73(8 Suppl):Abstract nr 2434.
13. Klinghammer K, Raguse JD, Siedmann M, Becker M, Keilholz U, Hoffmann J, Fichtner I. Establishment and characterization of patient-derived xenografts of head and neck tumors. [abstract]. In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research; 2013 Apr 6-10; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2013;73(8 Suppl):Abstract nr 2783. doi:10.1158/1538-7445.AM2013-2783

Andere (Patente)

1. Rekombinantes Zellsystem zur Deorphanisierung von G Protein-gekoppelten Rezeptoren. Aktenzeichen PCT/EP2004/012086 beim Europäischen Patentamt

Dr. Dr. Corinna Algermissen

Berufliche Ausbildung

Qualifikation und Weiterbildung

Akademische Ausbildung